Legal Representation
Attorney
Karl M. Zielaznicki, Esq.
USPTO Deadlines
Next Deadline
1358 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-04-11)
Due Date
April 11, 2029
Grace Period Ends
October 11, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 10, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Jul 9, 2025 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
Apr 11, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Apr 11, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Jan 24, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jan 24, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jan 4, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Dec 17, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Nov 29, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Nov 29, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 28, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
Oct 7, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Sep 20, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Sep 20, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Sep 20, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 13, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Dec 7, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Dec 7, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's diseases patients; pharmaceutical and diagnostic preparations for medical purposes for the treatment of fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's diseases patients; cellular functioning activating agents, biological or bacteriological preparations for medical purposes for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients; live cellular tissue implants in the nature of implants comprising living tissue or engineered live cellular tissue in the nature of implants comprising living tissue for medical purposes for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients
Classification
International Classes
005